4ISI
Structure of FACTOR VIIA in complex with the inhibitor (6S)-N-(4-CARBAMIMIDOYLBENZYL)-1-CHLORO-3-(CYCLOBUTYLAMINO)-8,8-DIETHYL-4-OXO-4,6,7,8-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE
Summary for 4ISI
| Entry DOI | 10.2210/pdb4isi/pdb |
| Related | 4ISH |
| Descriptor | Factor VII heavy chain, Factor VII light chain, (6S)-N-(4-carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,8-diethyl-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide, ... (5 entities in total) |
| Functional Keywords | glycoprotein, hydrolase, serine protease, plasma, blood coagulation factor, protein inhibitor complex, calcium-binding, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
| Biological source | Homo sapiens (human) More |
| Cellular location | Secreted: P08709 P08709 |
| Total number of polymer chains | 2 |
| Total formula weight | 34645.16 |
| Authors | |
| Primary citation | Zhang, X.,Glunz, P.W.,Jiang, W.,Schmitt, A.,Newman, M.,Barbera, F.A.,Bozarth, J.M.,Rendina, A.R.,Wei, A.,Wen, X.,Rossi, K.A.,Luettgen, J.M.,Wong, P.C.,Knabb, R.M.,Wexler, R.R.,Scott Priestley, E. Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF-FVIIa inhibitors. Bioorg.Med.Chem.Lett., 23:1604-1607, 2013 Cited by PubMed Abstract: Bicyclic pyrazinone and pyrimidinone amides were designed and synthesized as potent TF-FVIIa inhibitors. SAR demonstrated that the S2 and S3 pockets of FVIIa prefer to bind small, lipophilic groups. An X-ray crystal structure of optimized compound 9b bound in the active site of FVIIa showed that the bicyclic scaffold provides 5 hydrogen bonding interactions in addition to projecting groups for interactions within the S1, S2 and S3 pockets. Compound 9b showed excellent FVIIa potency, good selectivity against FIXa, Xa, XIa and chymotrypsin, and good clotting activity. PubMed: 23416003DOI: 10.1016/j.bmcl.2013.01.094 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.94 Å) |
Structure validation
Download full validation report






